Microneedling for Burn Hypertrophic Scars

Last updated: August 20, 2024
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Skin Wounds

Hyponatremia

Treatment

Microneedling

Clinical Study ID

NCT05423613
20.184
  • Ages 16-100
  • All Genders

Study Summary

Approximately 33 to 91% of severe burn victims will develop hypertrophic scars. Hypertrophic scars are defined as erythematous (red), raised and rigid scars that can cause pain and itching, among other things. They cause psychological distress and affect the quality of life of burn victims. Microneedling is a technique that uses an electrical device to create hundreds of microchannels that penetrate the skin layers. This study is interested in determining the effectiveness of microneedling in improving the pliability, thickness and erythema of hypertrophic scars. Each scar will receive up to 5 ACS-pen treatments followed by the application of cortisone (triamcinolone acetonide). Knowing that microneedling increases the absorption of products applied to the skin by about 80%, it is logical to think that creating these channels to the dermis and applying cortisone afterwards would have a beneficial effect on the hypertrophic scars of these patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Any gender or race

  • 16 years of age or older

  • Have at least 2 HSc that meet the clinical criteria for HSc

  • Provide written informed consent.

Exclusion

Exclusion Criteria:

  • Patients with keloid scars

  • Mature scar site

  • A psychiatric condition or cognitive impairment that interferes with their abilityto follow the treatment protocol

  • Dermatological conditions (i.e. psoriasis, eczema, etc.) in the area of theevaluation site

  • An allergy to ultrasound gel

  • On anticoagulant medications

  • Inability to understand English or French.

Study Design

Total Participants: 36
Treatment Group(s): 1
Primary Treatment: Microneedling
Phase:
Study Start date:
January 22, 2021
Estimated Completion Date:
June 20, 2026

Study Description

Patients will receive microneedling once every six weeks for a maximum of five treatments

Connect with a study center

  • Villa Medica Rehabilitation Hospital

    Montréal,
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.